[Federal Register Volume 72, Number 195 (Wednesday, October 10, 2007)]
[Notices]
[Pages 57593-57594]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 07-4988]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


National Institutes of Health; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, Review of one P01 Regulation of T 
Cell Immunity.
    Date: October 22, 2007.
    Time: 12:30 p.m. to 3:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge 6700, 6700B 
Rockledge Drive, Room 3266, Bethesda, MD 20817. (Telephone 
Conference Call).
    Contact Person: Katrin Eichelberg, PhD., Scientific Review 
Administrator, Scientific Review Program, Division of Extramural 
Activities, NIAID/NIH/DHHS, 6700B Rockledge Drive, MSC 7616, 
Bethesda, MD 20892, 301-496-0818, <a href="/cdn-cgi/l/email-protection#7318161a101b161f11160114331d1a121a175d1d1a1b5d141c05"><span class="__cf_email__" data-cfemail="1c7779757f7479707e796e7b5c72757d757832727574327b736a">[email protected]</span></a>.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, Novel HIV Therapies: Integrated 
Preclinical/Clinical Program (IPCP).
    Date: October 29-30, 2007.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.

[[Page 57594]]

    Place: Hilton Washington/Rockville, Double Tree Name Changed, 
1750 Rockville Pike, Rockville, MD 20852.
    Contact Person: Barney Duane Price, PhD., Scientific Review 
Administrator, Scientific Review Program, DHS/NIH/NIAID/DEA, Room 
3139, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892-7616, 301-
451-2592, <a href="/cdn-cgi/l/email-protection#1e6e6c777d7b7c7a5e70777f777a3070777630797168"><span class="__cf_email__" data-cfemail="38484a515b5d5a5c78565159515c16565150165f574e">[email protected]</span></a>.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: October 3, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-4988 Filed 10-9-07; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>